Why India rejected a patent application for shorter drug-resistant TB treatment | Explained
12 minutes ago · The Hindu
India
& newspaper;
Read Full Article →
Sourced From
The Hindu
The decision could open the door to greater generic competition, but its impact on treatment costs will depend on drug availability, pricing, and access to care
Source: The Hindu — Read full article →
Content sourced from third parties. Copyright belongs to original publishers.
Source: The Hindu — Read full article at source →
Content sourced from third parties. Copyright belongs to original publishers. Only excerpt and link are stored under fair use.